WHO we are ?

Dr. Cécile Bour

Dr Bour Cécile

Born in 1961 in Alès (Gard) , France ; French Baccalauréat in literature followed by Medical Studies at the University of Strasbourg.

I specialized in medical imaging and radiodiagnosis in Reims and Besançon, then I established as practitioner in a group medical office based the Messina region (Lorraine) in 1993. I started the senology in 1995 and then joined the departmental organization for breast cancer screening in Moselle, the AMODEMACES, for which I joined the committee of mammography reviewers (the second reading of mammograms). I participated for more than twenty years in the screening organized in our region. I resigned from AMODEMACES in 2015, no longer being convinced of this public health system. In 2015 I became a member of Formindep (French medical non-profit organization for an independent training of medical doctors) and founded the non-profit organization Cancer Rose, which fights for an objective information for women on breast cancer screening. I am currently its President.

I am an occasional reviewer for the medical magazine Prescrire.

 I was auditioned at the Ministry of Health by three high government officials before the Citizen Consultation on Breast Cancer Screening at the end of 2015, and then I participated in 2016 at  the citizen and scientific consultation on breast cancer screening initiated by Ms. Minister Marisol Touraine, French Health Minister, with a presentation for the citizen round table and a second one for the professional round table.

Teaching in initial medical training

- Since 2017 - Member of medical thesis jury

- Since 2020 - Director of dissertations on Sociology of Health as well as Midwives dissertations focused on breast cancer screening

Teaching in continuing medical education

- Since 2015 - Speaker at conferences / lectures / conventions for professionals and patients on breast cancer screening

- Lectures at international congresses ("Congress of the French Society of Breast Senology and Pathology", Lille 2017; "A couch on the Danube", Budapest 2018; "Preventing Overdiagnosis", Copenhagen 2018, "Colloque of Bobigny", Paris 2019, "International Days on Healthcare Partnership with the Patient, Côte d'Azur University", 2020)

Research and Publications

- 2016 - Speaker at the Citizen and Scientific Consultation on Breast Cancer Screening organized by the French Ministry of Health.

- "Does organized screening really make it possible to lighten the surgical treatment of breast cancer?". October 2017, Revue Médecine, volume 13, number 8. https://www.jle.com/fr/revues/med/e-docs/le_depistage_organise_permet_il_reellement_dalleger_le_traitement_chirurgical_des_cancers_du_sein__310529/article.phtml

And here a short summary of the adventures of a screener, in images.

Dr. Jean Doubovetzky

Jean Doubovetzky

General practitioner and senior editor of the medical journal Prescrire.

Born in Paris in 1957, he earned his French Baccalaureate in Science in 1975. In addition to his general medical cursus, he studied general medical psychology, emergency medicine, tropical medicine, and applied epidemiology.

Thereafter, his medical activity focuses on his office practice and refugee care, with temporary activities in emergency services.

He has also been a trainee teacher, a lecturer at the Faculty of Medicine in Toulouse, and as a teacher for continuing education.

His scientific and editorial activity focuses on the writing for the Prescrire journal, of which he has been a member since 1988. He has also been project manager for the writing of medical references and recommendations for national health agencies Andem and Anaes.

Dr. Doubovetzky has published a large number of medical articles (Prescrire, Que Choisir Santé) and has translated numerous books and articles.

Since 2015, he is a member of the independent Cancer-Rose collective on breast cancer screening. He is also a member of Formindep (association for independent medical education).

Dr. Doubovetzky has no links of interest with
pharmaceutical industry or the medical equipment
manufacturers, nor with their communications
agencies or insurance companies.

Dr. Emilie Franzin

Dr Emilie Franzin

I was born in 1980 in the Loir et Cher region of France, then I lived in Gers until I started my medical studies in Toulouse.
Since my fellowship medical training, I have discovered the presence of pharmaceutical laboratories in the hospital "staff". Yet I have been disturbed by their communication. A pharmacology professor made me discover that independent knowledge could be acquired by BIP31 and Prescrire medical journal. Prof. Montastruc, thank you.

As an intern, I was not yet armed enough to refuse staff and laboratory luncheons, however I did not feel comfortable. Then, during my replacement practice, I discovered that it was possible through peer groups or continuing medical education.

Since then, as a Gers collaborator as well as a member of Formindep since 2010, I have not received medical visitors.
As soon as I know that a laboratory is involved, I avoid all training, information meetings , conferences
(because sometimes you don't realize it until you're there).
I have never been able to convince a patient to do a mammography exam, when she didn't want it.
So, what a pleasure for me to discover that I was not alone and to join this dynamic and
constructive group in order to to provide patients with more loyal information.

Dr. Marc Gourmelon

Dr Marc Gourmelon

As a general practitioner for more than 30 years, I have been "wandering around" a little.
Until 2008 I was a "norm" doctor, which meant receiving medical visitors that the pharmaceutical industry sends to the doctor's office to inform them of the "advances" in medicine.
At the invitation of pharmaceutical companies, I frequently went to large hotels to attend continuing medical education courses organized under their 'kind' patronage. As a university graduate of nutrition, I have been very involved in the care of overweight patients. I was eagerly awaiting the introduction of the "miraculous" treatment for weight loss: Acomplia (Sanofi-Aventis). However, this drug was banned from sale on 28/02/2008 because it caused severe depression, which led to the death of several patients by suicide. This serious side effect has never been presented by the laboratory, quite the opposite.

This event has been the trigger. I recalled that there were many others like Vioxxor or Staltor before this drug. It was also at that time that the Mediator controversy began, and I knew the opinion of Prescrire magazine on the subject.
Then, I really became aware of the drug manufacturers' manipulations that I was being subjected to, whereby all the lies and manipulations were good enough to make me prescribe their drugs. I lost my confidence in the health care system and I decided not to believe any more on what the industry or the health authorities (mostly under the influence of industry) were saying. I started searching for the best medical practice myself. Since then, I have been guided by independence and transparency. In 2011 (or 2012) I joined the Formindep association (link).
It was about the same time that Rachel Campergue's book "No Mammo" was published.
Already aware that screening does not provide the benefits claimed, this book and the independent
research published later, convinced me that encouraging women to have a screening mammogram starting at the age of 50, did not provide the promised benefits. Moreover, the heavy marketing around this subject and the campaigns of October Rose led me to understand that women are "taken hostage".

Even more, they are manipulated since they are they are not honestly informed about the benefits and the risks of screening mammography. It is on the basis of this conviction, shared by four other doctors, that I have decided to mobilize with them to participate in this site, the aim of which is to provide the most objective information on the subject of October Rose and the concerns of breast cancer screening.

Dr. Vincent Robert

Dr Vincent Robert

Born in Lunéville (Lorraine) in 1955, I started my professional career in intensive care at the Metz-Thionville CHR (Regional Hospital Center) in 1985.

Currently retired since June 2020.

Interested in the health assessment, I took over the responsibility of the DIM (medical information department) of the Thionville Hospital Groups in 2000 when the PMSI was set up.

In 2010, I left the CHR to work at Alpha Santé in Hayange as head of DIM.

In 2012, I was recruited by Robert Schuman Hospital in Luxembourg to set up a DIM.

In parallel to these activities, I was President of the Clinical Research Commission of the Metz-Thionville CHR and a member of the CPP (Committee for the Protection of Persons) Est 3.

For the last ten years, I have lectured in statistics and epidemiology as a temporary lecturer at the University of Metz.

I have no interest links, either with the pharmaceutical or medical equipment industry or with insurance companies.

Dr. Robert contributed to the proofreading of the brochure and he is the main author of the study on mastectomies in France: jle.com

Dr. Annette Lexa

Dr Annette Lexa

I was born in 1960 in Longwy (France). I studied at the Faculty of Sciences in Nancy then in Metz. I hold a postgraduate diploma, a Master 2 in Ecotoxicology and a PhD in Toxicology, and I have been a researcher in collaboration with the pharmaceutical industry at the University of Metz for a long time (until 1997). I am the author of several books and publications on the history of science. At the regional level, I am a member of the Board of the Lorraine Academy of Science; for 10 years (2006-2016) I have been a member of the CODERST of Moselle (Departmental Commission on Environment, Health and Technological Risks) and have lectured at the “University of Permanent Culture” for many years.

At the national level, I have joined organisations such as the “Scientific Council of the Nicolas Hulot Foundation” and “Future Generation” and the Board of directors of CRIIGEN (Committee for Independent Research and Information on Genetic Engineering)

I have been registered on the list of European Toxicologists (EUROTOX) since 2009 and have specialized since 2008 in regulatory toxicology and health-environmental risk assessment, and I have set up my own company where I work as a consultant.(http://www.rcma-expert.eu/fr/).

My expertise has raised my awareness of health risk assessment and toxicology, in relation to the exposure to CMR substances (carcinogenic, reprotoxic, mutagenic), endocrine disruptors, ionising radiation endocrine disruptors, epidemiology and modelling.

I am an independent scientist, open-minded, curious, rigorous, passionate about the method and enjoying thinking further using the tools of philosophy and the history of sciences.

I have been interested in the controversy surrounding the interest of screening since 2005 ; this subject has been a matter of deep concern to me, as a woman and as a scientist.

I collaborate to the Cancer Rose website to introduce and document the views of an expert outside of the medical world.

Sophie, patient

Sophie, Patient

I contacted the Association Cancer Rose following a breast cancer screening exam.
This exam had caused anxiety for several reasons: a lack of information before and during the exam, a long wait for the result, an error on the information for the follow-up.
Thanks to the support of the Cancer Rose Group, as well as the reading of scientific papers published in prestigious international journals and the most recent data relayed on the website, I was able to restore my serenity.
I joined the association hoping that I, at my turn, I will be able to help other women to avoid these stressful situations.
Dear colleagues of Cancer Rose, I would like to take this opportunity to thank you for your unfailing support, your humanism and your time without counting.
I would also like to thank Dr. Bernard Duperray for his book "Breast Cancer Screening - The Great Illusion" which I have read and which I recommend to every woman to read before her screening exam.